These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6258973)

  • 41. Evaluation of a food intake model as a tool for studying cholecystokinin (CCK) and derivatives of CCK in male Sprague-Dawley rats.
    Wire WS; Fang SN; Hruby VJ; Farmer SC; Riviere P; Kramer TH; Burks TF
    Proc West Pharmacol Soc; 1990; 33():65-8. PubMed ID: 2274547
    [No Abstract]   [Full Text] [Related]  

  • 42. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K; Tamminga CA; Chase TN; Nilaver G
    Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholecystokinin and satiety in pigs.
    Anika SM; Houpt TR; Houpt KA
    Am J Physiol; 1981 May; 240(5):R310-8. PubMed ID: 6263113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppressive effect of cholecystokinin and its related peptides on beta-endorphin-induced catalepsy in rats.
    Itoh S; Katsuura G
    Eur J Pharmacol; 1981 Sep; 74(4):381-4. PubMed ID: 6271561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats.
    Glatzle J; Raybould HE; Kueper MA; Reeve JR; Zittel TT
    Nutr Neurosci; 2008 Apr; 11(2):69-74. PubMed ID: 18510806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8).
    Zetler G
    Neuropharmacology; 1980 May; 19(5):415-22. PubMed ID: 6248810
    [No Abstract]   [Full Text] [Related]  

  • 48. Cholecystokinin octapeptide induces hypothermia and improves outcomes in a rat model of cardiopulmonary resuscitation.
    Weng Y; Sun S; Song F; Phil Chung S; Park J; Harry Weil M; Tang W
    Crit Care Med; 2011 Nov; 39(11):2407-12. PubMed ID: 21705891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of thyrotrophic-releasing hormone (TRH) on thermoregulation in the rat.
    Lin MT; Chandra A; Chern YF; Tsay BL
    Experientia; 1980 Sep; 36(9):1077-8. PubMed ID: 6774889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurotensin induces catalepsy in mice.
    Snijders R; Kramarcy NR; Hurd RW; Nemeroff CB; Dunn AJ
    Neuropharmacology; 1982 May; 21(5):465-8. PubMed ID: 6810195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coinjection of CCK and leptin reduces food intake via increased CART/TRH and reduced AMPK phosphorylation in the hypothalamus.
    Akieda-Asai S; Poleni PE; Date Y
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1284-91. PubMed ID: 24735891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cholecystokinin octapeptide sulphate ester on brain monoamines in the rat.
    Fekete M; Várszegi M; Kádár T; Penke B; Kovács K; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 57(1):37-46. PubMed ID: 6269350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclic cholecystokinin analogues that are highly selective for rat and guinea pig central cholecystokinin receptors.
    Rodriguez M; Lignon MF; Galas MC; Amblard M; Martinez J
    Mol Pharmacol; 1990 Sep; 38(3):333-41. PubMed ID: 1698251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of intracerebroventricular administration of thyrotrophic-releasing hormone on cardiovascular function in the rat.
    Tsay BL; Lin MT
    Neuroendocrinology; 1982; 35(3):173-7. PubMed ID: 6813757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potent and sustained satiety actions of a cholecystokinin octapeptide analogue.
    Moran TH; Sawyer TK; Seeb DH; Ameglio PJ; Lombard MA; McHugh PR
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):286S-290S. PubMed ID: 1728841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of thyrotropin-releasing hormone in acid secretory response induced by lowering of body temperature in the rat.
    Niida H; Takeuchi K; Okabe S
    Eur J Pharmacol; 1991 Jun; 198(2-3):137-42. PubMed ID: 1907561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic intraventricular administration of cholecystokinin octapeptide (CCK-8) suppresses feeding in rats.
    Schick RR; Stevens CW; Yaksh TL; Go VL
    Brain Res; 1988 May; 448(2):294-8. PubMed ID: 3378151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of intravenous and intramuscular sincalide (C-terminal octapeptide of cholecystokinin) on gallbladder contraction in man.
    Lalyre Y; Wilson DE; Kidao J; Hall CH; Capek V
    Dig Dis Sci; 1981 Mar; 26(3):214-7. PubMed ID: 6263565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antagonism of ketamine-induced anesthesia and hypothermia by thyrotropin releasing hormone and cyclo(His-Pro).
    Bhargava HN
    Neuropharmacology; 1981 Jul; 20(7):699-702. PubMed ID: 6789227
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effect of cholecystokinin octapeptide on ethanol-induced changes in motor activity and in dopamine metabolism in the nucleus accumbens of the rat brain].
    Medvedeva OF; Sudakova SK; Anokhina IP; Kianmaa K
    Eksp Klin Farmakol; 1996; 59(6):44-7. PubMed ID: 9181874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.